Analyst Ratings for Immunocore Hldgs
Portfolio Pulse from Benzinga Insights
Immunocore Hldgs (NASDAQ:IMCR) has received positive analyst ratings in the last quarter, with 8 bullish and 4 somewhat bullish ratings. No bearish or indifferent ratings were observed. The company's average 12-month price target is $84.25, which has increased by 8.95% over the past month.
November 02, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immunocore Hldgs has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings are a significant factor that investors consider when making investment decisions. The positive ratings for Immunocore Hldgs indicate a positive outlook for the company, which could lead to increased investor interest and a potential increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100